Evidence map›Paper›PMID 37698755›Full record

ReviewCurrent HIV/AIDS reports2023

Integrated Care Models: HIV and Substance Use.

Katherine Hill, Irene Kuo, Sheela V Shenoi, Mahalia S Desruisseaux, Sandra A Springer

Registry-linked trialAbstract readReview
In one paragraph

Review in Current HIV/AIDS reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07414459 (Combining Social Network Strategies and Routine Substance Use Screening), which is not on this map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07414459 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

Combining Social Network Strategies and Routine Substance Use Screening

TypeinterventionalSponsorUniversity of California, San DiegoRan2026 to 2029Enrolled500ConditionsHIV, Substance Use Disorder (SUD)ArmsSubstance use disorder screening, Social network intervention
3 · Its place in the literature

Who cites it

30 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Integrating HIV and Stimulant-Use Disorder Treatment: A Pilot Implementation Effectiveness Trial of Contingency Management in HIV Care.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026
    Article
  9. Review
  10. Brief Report: Availability of Substance Use Services at US HIV Care Facilities by Urbanicity.Journal of acquired immune deficiency syndromes (1999) · 2026
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Katherine HillDepartment of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA.
Irene KuoDepartment of Epidemiology, Milken Institute School of Public Health at The George Washington University, Washington, DC, USA.
Sheela V ShenoiDepartment of Internal Medicine, Section of Infectious Diseases, AIDS Program, Yale School of Medicine, 135 College Street, Suite 323, New Haven, CT, 06510, USA.ORCID 0000-0001-7654-4344
Mahalia S DesruisseauxYale Institute of Global Health, New Haven, CT, USA.ORCID 0000-0003-2060-412X
Sandra A SpringerDepartment of Internal Medicine, Section of Infectious Diseases, AIDS Program, Yale School of Medicine, 135 College Street, Suite 323, New Haven, CT, 06510, USA. Sandra.springer@yale.edu.ORCID 0000-0002-6318-1000

Funding

Long-acting buprenorphine vs. naltrexone opioid treatments in CJS-involved adultsU01DA047982 · NIDA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI FARABEE, DAVID J, GRYCZYNSKI, JAN · 2019 to 2024
$20.3M
Addressing risk through Community Treatment for Infectious disease and Opioid use disorder Now (ACTION) among justice-involved populationsU01DA053039 · NIDA · YALE UNIVERSITY · PI KNIGHT, KEVIN, NIJHAWAN, ANK ELISABETH · 2020 to 2025
$12.1M
Ending HIV: Bringing Integrated Prevention and Treatment Services to People Who Use Drugs Where They LiveDP1DA056106 · NIDA · YALE UNIVERSITY · PI SANDRA Ann SPRINGER · 2022 to 2026
$6.0M
SIGNAL TRANSDUCTION IN CLONED OPIOID RECEPTORSF32DA005610 · NIDA · UNIVERSITY OF WASHINGTON · PI HENRY, DOUGLAS J · 1994 to 1996
–
NIDA NIH HHS DP1DA05610NIDA NIH HHS DP1 DA056106NIDA NIH HHS U01DA04798NIDA NIH HHS U01 DA047982NIDA NIH HHS U01 DA053039
6 · The paper itself

Abstract

purpose of reviewBehaviors and practices associated with substance use contribute to lack of HIV virologic suppression and onward transmission. In the USA, many recent HIV outbreaks have been connected with substance use. Evidence-based strategies for integrating care of those at risk for and living with HIV and who use substances continue to evolve. This review, based on scientific and medical literature through March 2023, provides an overview and evaluation of initiatives for integrated care aimed to serve patients at risk for and with HIV and a substance use disorder. RECENT

findingsIntegrated care services can improve health outcomes for patients at risk for and with HIV and a substance use disorder; for instance, treatment for an opioid use disorder can help improve HIV viral suppression. Brick-and-mortar facilities can provide successful care integration with appropriate clinic leadership to support multidisciplinary care teams, up-to-date provider training, and sufficient pharmacy stock for substance use treatment. Delivering healthcare services to communities (e.g., mobile healthcare clinics and pharmacies, telehealth) may prove to be an effective way to provide integrated services for those with or at risk of HIV and substance use disorders. Incorporating technology (e.g., mobile phone applications) may facilitate integrated care. Other venues, including harm reduction programs and carceral settings, should be targets for integrated services. Venues providing healthcare should invest in integrated care and support legislation that increases access to services related to HIV and substance use.

Indexed as

Delivery of Health Care, IntegratedHIV InfectionsOpioid-Related DisordersHealth ServicesHumansHarm reductionHIVIntegrated care modelsMedication treatment of opioid use disordersMobile health clinicsSubstance use disorder

Identifiers

PMID37698755
PMCPMC11034717

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.